ArticleEuropean geriatric medicine2026
How do falls-risk increasing drugs modify the association between index falls and future falls and fracture burden? Secondary data analysis from the Irish longitudinal study on ageing.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundFalls are a major tipping point in older adults, heralding functional decline and increased healthcare utilisation. Falls-risk-increasing drugs (FRIDs) are a key risk factor for falls, but their influence on outcomes when prescribed after a fall is under-examined. This study examined the association between an index fall requiring medical attention and subsequent 2-year risk of falls and fractures, evaluating how FRID use modifies this relationship.
methodsWe analysed data from Waves 5 and 6 of The Irish Longitudinal Study on Ageing, including participants ≥ 70 years with 2-year follow-up. FRIDs were identified from medication lists using STOPPFall. Regression models were used to assess the association between index falls and falls/fracture outcomes during follow-up: Falls, falls requiring medical attention, emergency department visits due to falls, and fractures. Two-way interactions were used to assess how FRID use modified this association.
resultsOf 1717 participants, 14% reported a fall requiring medical attention at baseline; 38% were prescribed ≥ 1 FRID. Index falls were associated with increased future falls (OR 2.65), falls requiring medical attention (OR 3.82), ED attendance due to a fall (OR 2.93), and fractures (OR 2.46) over 2 years (all p < 0.01). Combined exposure to both a fall and FRIDs further amplified risk, with odds ratios ranging from 3.77 to 4.36 across outcomes.
conclusionA fall requiring medical attention is a strong predictor of future falls burden, and FRID use significantly amplifies this risk. These findings highlight the need for targeted medication review within comprehensive geriatric assessment for older people with falls.
Indexed as
Identifiers
42521920What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.